US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

261.30

-4.7000-1.77%

Post-market: 261.300.00000.00%19:58 EDT

Volume:227.38K

Turnover:60.97M

Market Cap:489.80M

PE:- -

High:278.96

Open:273.29

Low:261.30

Close:266.00

52wk High:341.93

52wk Low:74.95

Shares:1.87M

Float Shares:1.87M

Volume Ratio:0.94

T/O Rate:12.13%

Dividend:1.00

Dividend Rate:0.38%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Urumqi Allows Flexible Employment Workers to Access Maternity Insurance Starting September

Ramsay Health Care Limited (ASX:RHC) Pays A AU$0.485 Dividend In Just Three Days

Simply Wall St.

Omega Healthcare Investors (OHI) Stock Still Looks Below Fair Value Despite 102% Returns

Simply Wall St.

Rici Healthcare Holdings (SEHK:1526) Stock Caught Between Low P E And Softer Profit

Simply Wall St.

Schwab US Dividend Equity ETF Sees Inflows Amid Healthcare Developments

Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Spyre Therapeutics (SYRE)

What AMN Healthcare Services (AMN)'s New Nursing Leadership Council Role Means For Shareholders

Simply Wall St.

Aster DM Quality Care to Merge Hospitality Subsidiaries for Structural, Operational Gains

Neurocrine Biosciences (NBIX) Cleared An FDA Milestone, Is It Trading At A Discount?

Simply Wall St.

National Healthcare Insider Makes Major Move in High-Value Stock Sale

Insider Move: Sensus Healthcare Director Quietly Boosts His Stake in the Company

Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO

Takeda's Mimrylo Gets FDA Approval to Treat Blood Cancer Condition

Takeda receives FDA approval of NDA for Mimrylo

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/LABU/news?page=21"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":261.3,"timestamp":1789156800000,"preClose":266,"halted":0,"volume":227375,"hourTrading":{"tag":"盘后","latestPrice":261.3,"preClose":261.3,"latestTime":"19:58 EDT","volume":728,"amount":191085.61070000002,"timestamp":1789171090575,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.017669172932330786,"floatShares":1874486,"shares":1874486,"eps":0,"marketStatus":"Market Closed","change":-4.7,"latestTime":"09-11 16:00:00 EDT","open":273.29,"high":278.9613,"low":261.3,"amount":60966581,"amplitude":0.066396,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":266,"sharesOutstanding":3074486,"nav":265.381,"aum":497453688.27,"dividendRate":0.003844,"bidAskSpread":0.003628,"preHourTrading":{"tag":"盘前","latestPrice":275.47,"preClose":266,"latestTime":"09:29 EDT","volume":10261,"amount":2778902.210600002,"timestamp":1789133394303,"change":9.47,"changeRate":0.035602,"amplitude":0.035677},"postHourTrading":{"tag":"盘后","latestPrice":261.3,"preClose":261.3,"latestTime":"19:58 EDT","volume":728,"amount":191085.61070000002,"timestamp":1789171090575,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9397711565267511,"impliedVol":0.8728,"impliedVolPercentile":0.3227},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1874486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9397711565267511,"shares":1874486,"dividePrice":1.0045,"high":278.9613,"amplitude":0.066396,"preClose":266,"low":261.3,"week52Low":74.95,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":261.3,"eps":0,"divideRate":0.003844,"volume":227375,"delay":0,"ttmEps":0,"open":273.29,"prevYearClose":159.39,"prevWeekClose":303.55,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":305.86,"twentyDayClose":273.91,"sixtyDayClose":184.63},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:21,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1137999186","title":"Urumqi Allows Flexible Employment Workers to Access Maternity Insurance Starting September","url":"https://stock-news.laohu8.com/highlight/detail?id=1137999186","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137999186?lang=en_us&edition=fundamental","pubTime":"2026-08-30 15:40","pubTimestamp":1788075623,"startTime":"0","endTime":"0","summary":"Authorities in Urumqi have announced that flexible employment workers will soon be eligible for maternity insurance coverage. A recent joint notice from six municipal departments, including the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4588","BK4581","XLV","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663041045","title":"Ramsay Health Care Limited (ASX:RHC) Pays A AU$0.485 Dividend In Just Three Days","url":"https://stock-news.laohu8.com/highlight/detail?id=2663041045","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663041045?lang=en_us&edition=fundamental","pubTime":"2026-08-30 08:45","pubTimestamp":1788050724,"startTime":"0","endTime":"0","summary":"Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-rhc/ramsay-health-care-shares/news/ramsay-health-care-limited-asxrhc-pays-a-au0485-dividend-in","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-rhc/ramsay-health-care-shares/news/ramsay-health-care-limited-asxrhc-pays-a-au0485-dividend-in","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VIG","GXDW","RHC.AU","VGFPF","DECU","BK7113","FEBU","RGLO","XLV","VOTE","JOYT","XBI","BK4581","LABU","BK4585","BK4588","PMDE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663043433","title":"Omega Healthcare Investors (OHI) Stock Still Looks Below Fair Value Despite 102% Returns","url":"https://stock-news.laohu8.com/highlight/detail?id=2663043433","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663043433?lang=en_us&edition=fundamental","pubTime":"2026-08-30 07:21","pubTimestamp":1788045717,"startTime":"0","endTime":"0","summary":"Omega Healthcare Investors has more than doubled shareholders' money over the past five years, yet several valuation checks still point to the stock trading at a discount to its estimated intrinsic value. With the share price recently at US$45.99 and short term returns under pressure, investors are weighing how much of that long term gain is already reflected in today’s valuation.\n\nOmega Healthcare Investors has returned 101.6% over five years. This puts the recent pullback in context as a...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/324452-main-header/1585187590195","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/324452-main-header/1585187590195"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-ohi/omega-healthcare-investors/news/omega-healthcare-investors-ohi-stock-still-looks-below-fair","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-ohi/omega-healthcare-investors/news/omega-healthcare-investors-ohi-stock-still-looks-below-fair","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GXDW","SPHQ","TACU","BK4225","RGLO","BK4585","XBI","BK4203","JOYT","VOTE","SRHR","DECU","BK4588","OHI","BK4581","PMDE","XLV","TSPA","FEBU","VGFPF","SRET","CDIG","DCF","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663483820","title":"Rici Healthcare Holdings (SEHK:1526) Stock Caught Between Low P E And Softer Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2663483820","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663483820?lang=en_us&edition=fundamental","pubTime":"2026-08-30 04:36","pubTimestamp":1788035805,"startTime":"0","endTime":"0","summary":"Rici Healthcare Holdings entered this earnings day with a stock that has fallen 21% over the past month, even as trailing earnings support a P/E of just 3.7x against a much higher sector average. The headline from the latest half year is clear: profit growth has cooled sharply, with H1 2026 net income of ¥45.6m and basic earnings per share of ¥0.03.\nThe expectation gap now sits squarely on earnings quality. Margins over the past twelve months remain in double digits; however, the latest half...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6033000-choice2-main-header/1585186569462","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6033000-choice2-main-header/1585186569462"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-1526/rici-healthcare-holdings-shares/news/rici-healthcare-holdings-sehk1526-stock-caught-between-low-p","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-1526/rici-healthcare-holdings-shares/news/rici-healthcare-holdings-sehk1526-stock-caught-between-low-p","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VGFPF","XLV","BK4585","DECU","XBI","BK4588","JOYT","LABU","VOTE","BK4137","BK1209","FEBU","LU0029874061.USD","GXDW","RGLO","LU0128526141.USD","BK4581","PMDE","HCSG","01526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663715017","title":"Schwab US Dividend Equity ETF Sees Inflows Amid Healthcare Developments","url":"https://stock-news.laohu8.com/highlight/detail?id=2663715017","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663715017?lang=en_us&edition=fundamental","pubTime":"2026-08-30 00:01","pubTimestamp":1788019278,"startTime":"0","endTime":"0","summary":"Schwab US Dividend Equity ETF ( $SCHD ) has fallen by 0.88% in the past week. It has experienced a 5-day net inflow of $640.6 million. This is due,...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/schwab-us-dividend-equity-etf-sees-inflows-amid-healthcare-developments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/schwab-us-dividend-equity-etf-sees-inflows-amid-healthcare-developments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","XLV","LABU","LU0128526141.USD","XBI","EQR","REZ","BK4137","LU0029874061.USD","BK4550","BK4581","SCHD","FDN","BK4588","HCSG","BK4215"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663464017","title":"Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Spyre Therapeutics (SYRE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2663464017","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663464017?lang=en_us&edition=fundamental","pubTime":"2026-08-29 22:30","pubTimestamp":1788013830,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Revolution Medicines (RVMD) and Spyre Therapeutics (...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-and-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-and-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","HCSG","BK4139","LABU","IE00B4R5TH58.HKD","LU0029874061.USD","IE00BJT1NW94.SGD","RVMD","LU0320765992.SGD","BK4581","CANC","LU0889565916.HKD","IDNA","IE0002141913.USD","IE0009355771.USD","BK4588","SYRE","IE00BFTCPJ56.SGD","IE0009354923.USD","PTH","LFSC","IE00BJJMRZ35.SGD","LU0109394709.USD","BK4137","LU0128526141.USD","IE00B2B36J28.USD","BBH","XLV","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663017727","title":"What AMN Healthcare Services (AMN)'s New Nursing Leadership Council Role Means For Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2663017727","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663017727?lang=en_us&edition=fundamental","pubTime":"2026-08-29 22:20","pubTimestamp":1788013257,"startTime":"0","endTime":"0","summary":"AMN Healthcare Services recently joined the AONL Foundation Corporate Advisory Council, where it will be represented by Chief Nursing Executive Dr. Angelo Venditti and Head of Strategic Enterprise & Channel Partnerships Steven Endsley to support research, innovation and education in nursing leadership nationwide.\nThis council role gives AMN a platform to shape workforce innovation and nursing leadership priorities, aligning its workforce-planning and analytics capabilities with national...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-amn/amn-healthcare-services/news/what-amn-healthcare-services-amns-new-nursing-leadership-cou","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-amn/amn-healthcare-services/news/what-amn-healthcare-services-amns-new-nursing-leadership-cou","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7095","AMN.AU","AMN","LABU","XBI","BK4588","BK4585","BK4196","XLV","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663017625","title":"Aster DM Quality Care to Merge Hospitality Subsidiaries for Structural, Operational Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2663017625","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663017625?lang=en_us&edition=fundamental","pubTime":"2026-08-29 21:12","pubTimestamp":1788009157,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Aster DM Healthcare Ltd. ( ($IN:ASTERDM) ). Aster DM Quality Care Limited has announced that the boards of its ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aster-dm-quality-care-to-merge-hospitality-subsidiaries-for-structural-operational-gains?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aster-dm-quality-care-to-merge-hospitality-subsidiaries-for-structural-operational-gains?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","BK4588","BK4581","XLV","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663017369","title":"Neurocrine Biosciences (NBIX) Cleared An FDA Milestone, Is It Trading At A Discount?","url":"https://stock-news.laohu8.com/highlight/detail?id=2663017369","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663017369?lang=en_us&edition=fundamental","pubTime":"2026-08-29 17:19","pubTimestamp":1787995165,"startTime":"0","endTime":"0","summary":"FDA milestone puts Neurocrine Biosciences in focus\nThe FDA’s acceptance of Neurocrine Biosciences (NBIX) Investigational New Drug application for NBI-1117567 clears the way for a Phase 2 trial in Alzheimer’s cognition and triggers a US$10 million payment to partner Nxera Pharma.\nDespite the FDA milestone, Neurocrine Biosciences’ recent share price momentum has cooled, with the 30 day share price return down 14.79%, even as the year to date share price return is up 9.57% and the 5 year total...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nbix/neurocrine-biosciences/news/neurocrine-biosciences-nbix-cleared-an-fda-milestone-is-it-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nbix/neurocrine-biosciences/news/neurocrine-biosciences-nbix-cleared-an-fda-milestone-is-it-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","LU0154245673.USD","LU0320765992.SGD","LU2065171402.SGD","LU2065171311.SGD","BK4588","NBIX","LU0823416689.USD","LU2065170008.USD","BK4139","LU0154245756.USD","CDIG","LU0109394709.USD","LU0889565916.HKD","LU2065169927.USD","LU2324357040.USD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663011983","title":"National Healthcare Insider Makes Major Move in High-Value Stock Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2663011983","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663011983?lang=en_us&edition=fundamental","pubTime":"2026-08-29 10:10","pubTimestamp":1787969445,"startTime":"0","endTime":"0","summary":"New insider activity at National Healthcare ( ($NHC) ) has taken place on August 28, 2026. Director David R. Gifford has recently sold 1,779 shares...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/national-healthcare-insider-makes-major-move-in-high-value-stock-sale-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/national-healthcare-insider-makes-major-move-in-high-value-stock-sale-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","NHC","XLV","BK4588","BK4585","BK4581","BK4185","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663011614","title":"Insider Move: Sensus Healthcare Director Quietly Boosts His Stake in the Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2663011614","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663011614?lang=en_us&edition=fundamental","pubTime":"2026-08-29 10:10","pubTimestamp":1787969423,"startTime":"0","endTime":"0","summary":"New insider activity at Sensus Healthcare ( ($SRTS) ) has taken place on August 28, 2026. Director Eric Sachetta has increased his stake in Sensus ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/insider-move-sensus-healthcare-director-quietly-boosts-his-stake-in-the-company-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/insider-move-sensus-healthcare-director-quietly-boosts-his-stake-in-the-company-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","SRTS","XBI","BK4585","BK4581","LABU","BK4082","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663019703","title":"Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663019703","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663019703?lang=en_us&edition=fundamental","pubTime":"2026-08-29 08:52","pubTimestamp":1787964735,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Co ( ($JP:4502) ) just unveiled an announcement. Takeda has secured U.S. FDA approval for MIMRYLO (rusfertide), a first-in-cl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLVX","MRNY","IEIH","RSPH","MRNX","BMED","LFSC","SYNB","TBXU","NVIB","FRTY","TECB","BK4588","PSCH","IBB","MEDI","BBP","PINK","BK4585","GNMX","LABU","GDOC","IYH","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016729","title":"Takeda's Mimrylo Gets FDA Approval to Treat Blood Cancer Condition","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016729","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663016729?lang=en_us&edition=fundamental","pubTime":"2026-08-29 07:02","pubTimestamp":1787958120,"startTime":"0","endTime":"0","summary":"Takeda's treatment for erythrocytosis in adults with polycythemia vera, a form of blood cancer, received approval from the Food and Drug Administration.The company said Friday that the FDA approved its new drug application for Mimrylo, also known as rusfertide. The drug treats adults with erythrocytosis who have PV, a condition involving an abnormally high concentration of red blood cells.\"The approval of Mimrylo underscores the strength of Takeda's late-stage pipeline and our focus on developing genuinely differentiated therapies for patients who are urgently waiting for new options,\" Chief Executive Julie Kim said.The development does not impact Takeda's guidance for the current fiscal year, the company said.The agency's approval was based on data from the company's Phase 3 trial of the treatment. An open-label extension of that trial is continuing, and the company said it is engaging with international regulators about the drug.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4007","TAK","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016033","title":"Takeda receives FDA approval of NDA for Mimrylo","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016033","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663016033?lang=en_us&edition=fundamental","pubTime":"2026-08-29 07:00","pubTimestamp":1787958013,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced U.S. FDA approval of the New Drug Application for Mimrylo for the treatment of erythrocytosis in adults with polycythemia ve...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FRTY","BBP","BK4007","IYH","NVIB","IDNA","IEIH","GNMX","TECB","MRNY","BK4588","PSCH","SYNB","PINK","IBB","LFSC","MRNX","TAK","TBXU","GDOC","BMED","XLVX","BK4585","LABU","MEDI","RSPH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":21,"totalSize":414,"code":"91000000","status":"200"}]}}